标题
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
作者
关键词
-
出版物
Genes
Volume 12, Issue 5, Pages 727
出版商
MDPI AG
发表日期
2021-05-13
DOI
10.3390/genes12050727
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The association between ATM variants and risk of breast cancer: a systematic review and meta-analysis
- (2021) Masoumeh Moslemi et al. BMC CANCER
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
- (2021) et al. NEW ENGLAND JOURNAL OF MEDICINE
- Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple Cancers
- (2021) Michael J. Hall et al. Cancer Prevention Research
- Heterozygous germline ATM mutations in breast cancer: A single academic center experience.
- (2020) Anish S Konde et al. JOURNAL OF CLINICAL ONCOLOGY
- Current clinical management of elderly patients with glioma
- (2020) Alessia Pellerino et al. Expert Review of Anticancer Therapy
- Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
- (2020) Zhen Li et al. Frontiers in Pharmacology
- Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
- (2019) Marco Tucci et al. Frontiers in Oncology
- Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
- (2019) Francesco Mannavola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comprehensive profiling of DNA repair defects in breast cancer identifies a novel class of endocrine therapy resistance drivers
- (2018) Meenakshi Anurag et al. CLINICAL CANCER RESEARCH
- Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer
- (2017) Svasti Haricharan et al. Cancer Discovery
- Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline
- (2016) N.J.H. van Os et al. CLINICAL GENETICS
- Penetrance ofATMGene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk
- (2016) Monica Marabelli et al. GENETIC EPIDEMIOLOGY
- PALB2,CHEK2andATMrare variants and cancer risk: data from COGS
- (2016) Melissa C Southey et al. JOURNAL OF MEDICAL GENETICS
- ATM Mutations in Cancer: Therapeutic Implications
- (2016) M. Choi et al. MOLECULAR CANCER THERAPEUTICS
- ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells
- (2015) M. Kwok et al. BLOOD
- Avβ3 integrin: Pathogenetic role in osteotropic tumors
- (2015) Stefania Stucci et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
- (2015) Douglas F. Easton et al. NEW ENGLAND JOURNAL OF MEDICINE
- ATM kinase sustains HER2 tumorigenicity in breast cancer
- (2015) Venturina Stagni et al. Nature Communications
- The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo
- (2015) Frank P. Vendetti et al. Oncotarget
- Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents
- (2014) Yuxia Cui et al. CELL CYCLE
- Low ATM protein expression and depletion of p53 correlates with olaparib sensitivity in gastric cancer cell lines
- (2014) Eiji Kubota et al. CELL CYCLE
- ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas
- (2013) R. C. Bueno et al. ANNALS OF ONCOLOGY
- Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
- (2013) Kathryn P. Pennington et al. CLINICAL CANCER RESEARCH
- ATM signalling and cancer
- (2013) C A Cremona et al. ONCOGENE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Chromatin Remodeling Underlies the Senescence-Associated Secretory Phenotype of Tumor Stromal Fibroblasts That Supports Cancer Progression
- (2012) E. Pazolli et al. CANCER RESEARCH
- Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53
- (2012) Chris T. Williamson et al. EMBO Molecular Medicine
- Deficient DNA Damage Signaling Leads to Chemoresistance to Cisplatin in Oral Cancer
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- PIDD Death-Domain Phosphorylation by ATM Controls Prodeath versus Prosurvival PIDDosome Signaling
- (2012) Kiyohiro Ando et al. MOLECULAR CELL
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- BRCAness: Finding the Achilles Heel in Ovarian Cancer
- (2012) G. Rigakos et al. ONCOLOGIST
- A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity
- (2011) Sylwia Kabacik et al. CELL CYCLE
- Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways
- (2011) Marlen Keimling et al. FASEB JOURNAL
- A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF- B and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage
- (2011) Y. Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- miR-18a Impairs DNA Damage Response through Downregulation of Ataxia Telangiectasia Mutated (ATM) Kinase
- (2011) Libing Song et al. PLoS One
- The Phenotypic Radiation Resistance of CD44+/CD24−or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
- (2011) Hong Yin et al. PLoS One
- ATM Mutations in Patients with Hereditary Pancreatic Cancer
- (2011) Nicholas J. Roberts et al. Cancer Discovery
- Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
- (2010) Massimo Squatrito et al. CANCER CELL
- Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls
- (2010) O. Fletcher et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Discovering moderate-risk breast cancer susceptibility genes
- (2010) Antoinette Hollestelle et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J
- (2010) Wooi Loon Ng et al. DNA REPAIR
- The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis
- (2010) Lin-Bo Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women's Environmental Cancer and Radiation Epidemiology Study
- (2010) Jonine L. Bernstein et al. JNCI-Journal of the National Cancer Institute
- The combined status of ATM and p53 link tumor development with therapeutic response
- (2009) H. Jiang et al. GENES & DEVELOPMENT
- WIP1 phosphatase at the crossroads of cancer and aging
- (2009) Xavier Le Guezennec et al. TRENDS IN BIOCHEMICAL SCIENCES
- Variants in the ATM gene and breast cancer susceptibility
- (2009) Roger L Milne Genome Medicine
- Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk
- (2008) M. Mitui et al. HUMAN MUTATION
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started